We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Crism Therapeutics Corp | AQSE:AMC.GB | Aquis Stock Exchange | Ordinary Share | VGG042401262 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 8.00 | 14.00 | 11.00 | 11.00 | 11.00 | 0.00 | 06:59:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMC
RNS Number : 0768X
Amur Minerals Corporation
24 August 2022
24 August 2022
AMUR MINERALS CORPORATION
(AIM: AMC)
Result of General Meeting
Amur Minerals Corporation ("Amur" or the "Company"), the nickel-copper sulphide mineral exploration and resource development company focused on the far east of Russia, is pleased to announce that the resolution put to Shareholders at the General Meeting held today at 10:00 a.m. in connection with the proposed Disposal of Kun-Manie announced on 08 August 2022 was passed.
The total number of votes received on the resolution is as follows:
Votes For % In Votes % Against Votes % of Available Votes & Discretionary Favour Against Total Voting Rights* Withheld Resolution 1 297,476,633 93.76 19,810,447 6.24 317,365,617 20.56 76,537 ----------------- -------- ----------- ---------- ------------ ---------------- ----------
* Available Voting Rights equals 1,392,872,315.
The Disposal remains conditional on:
-- the consent of the Federal Antimonopoly Service of Russia or its relevant territorial department to the Disposal being granted and such consent not being conditional upon any further actions or omissions by any of the parties to the Share Purchase Agreement;
-- the approval under the Presidential Decree No. 81 dated 1 March 2022 and all ensuing Russian Federation regulatory statutes having been granted on the terms required by applicable law, and not having been subsequently revoked, and such approval not being conditional upon any further actions or omissions by any party.
Robin Young, CEO of Amur, commented: "We are pleased with approval of the Disposal. Firstly, on behalf of the Company, I would like to thank the shareholders for their patience and support. The approved Disposal has addressed the shareholders concerns following the previously attempted disposal where in a more suitable structure and the declaration of a special dividend to be paid post receipt of the closing payment were included. We shall also assess various alternatives and considerations with regard to the impact on shareholder taxation of the dividend on completion of the Disposal upon payment of the funds.
"With the approval of the disposal, we shall also be updating the shareholders as to our forward looking strategy to consider the undertaking of a Reverse Take Over. Following receipt of the payment, we will turn our full attention to the future of the Company where we endeavor to identify and secure another business opportunity to deliver value to shareholders."
Future Strategy and Special Dividend
Now that the Disposal is approved by shareholders and assuming the outstanding conditions are satisfied in accordance with its terms, the Company will move forward as an AIM Rule 15 cash shell and retain cash balances of approximately US$39 million after paying certain expenses and any taxes relating to the Disposal.
Following receipt of the consideration of US$ 35 million, the Company intends to pay a special dividend of 1.8 pence per share to be paid to Shareholders within 90 days of Completion. The Company has received tax advice that the Disposal is unlikely to attract capital gains or withholding tax to the Company. The Board proposes that the record date and payment date for the distribution of the post-Completion dividend shall be no later than 90 days following receipt of the consideration payment.
The Directors intend to seek to acquire another company or business in exchange for the issue of Ordinary Shares in a single transaction (a "reverse takeover"), which will be subject to Shareholder approval. In considering the Company's future strategy, the Board will seek to identify opportunities offering the potential to deliver value creation and returns to Shareholders over the medium to long-term in the form of capital and / or dividends.
The Company will be required to undertake an acquisition or acquisitions which constitute(s) a reverse takeover under AIM Rule 14 on or before the date falling six months from the completion of the Disposal, or be re-admitted to trading on AIM as an investing company under AIM Rule 8. Failing that, the Company's Ordinary Shares would then be suspended from trading on AIM pursuant to AIM Rule 40. If the Company's shares remain suspended for six months, admission of the Company's shares will be cancelled.
Terms used and not defined in this announcement shall have the same meanings given to them in the Circular sent to shareholders on 8 August 2022.
Market Abuse Regulation (MAR) Disclosure)
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Company Nomad and Broker Public Relations Amur Minerals S.P. Angel Corporate BlytheRay Corp. Finance LLP Robin Young CEO Richard Morrison Megan Ray Adam Cowl Tim Blythe +44 (0) 7981 126 +44 (0) 20 7138 818 +44 (0) 20 3470 0470 3203
For additional information on the Company, visit the Company's website, www.amurminerals.com .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ROMSELSULEESEEA
(END) Dow Jones Newswires
August 24, 2022 05:26 ET (09:26 GMT)
1 Year Crism Therapeutics Chart |
1 Month Crism Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions